The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of induction chemoimmunotherapy (ICI) with cemiplimab in combination with cisplatin and docetaxel (TPI) in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
 
Omayra Sanchez
No Relationships to Disclose
 
Leslie Worona
Consulting or Advisory Role - Fennec Pharma; Naveris
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - Merck
 
Emily Ramos
No Relationships to Disclose
 
Vruti Virani
No Relationships to Disclose
 
Marshall Posner
Honoraria - Naveris
Consulting or Advisory Role - Aveo; Calliditas Therapeutics; Galeria; Merck; Merus
Research Funding - BioNTech (Inst); Flamingo Pharma (Inst); Gilead Sciences (Inst); Hookipa Pharma (Inst); ISA Pharmaceuticals (Inst); Regeneron (Inst); Toragen (Inst)
Patents, Royalties, Other Intellectual Property - anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor
(OPTIONAL) Uncompensated Relationships - Frizent; Vivan Therapeutics
 
Scott Roof
No Relationships to Disclose
 
Kunal Sindhu
No Relationships to Disclose
 
Richard Bakst
No Relationships to Disclose
 
Eric Genden
No Relationships to Disclose
 
Krzysztof Misiukiewicz
Consulting or Advisory Role - Merck